Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any renal-hepatic-pancreatic dysplasia in which the cause of the disease is a mutation in the NEK8 gene.
Features include always present findings: Femoral bowing, Enlarged cisterna magna, and Malformation of the hepatic ductal plate; and common findings: Oligohydramnios, Truncus arteriosus, Pulmonary hypoplasia, and Situs inversus totalis and others. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 5 | Cholestasis, Liver scarring (fibrosis) (hepatic fibrosis), Enlarged liver (hepatomegaly) |
NEK8 encodes NIMA related kinase 8 (692 aa). Required for renal tubular integrity. May regulate local cytoskeletal structure in kidney tubule epithelial cells. May regulate ciliary biogenesis through targeting of proteins to the cilia. Highest expression in Cells EBV-transformed lymphocytes (18.6 TPM) and Thyroid (18.3 TPM).
Renal-hepatic-pancreatic dysplasia 2 is caused by mutations in the NEK8 gene on chromosome 17.
NEK8 is classified as a druggable target (Druggable Genome, Enzyme, Kinase, and Serine Threonine Kinase categories) with score 0.0.
Genetic testing for NEK8 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 10 common features.
No clinical trials have been registered for renal-hepatic-pancreatic dysplasia 2.
1 publication has been identified in PubMed for renal-hepatic-pancreatic dysplasia 2. Research spans Review / Meta-Analysis (100%).
Roig J (2025). [PMID: 40189576](https://pubmed.ncbi.nlm.nih.gov/40189576/). *Cell communication and signaling : CCS*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 6:53 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Heart and blood vessels | 2 | Aortic valve stenosis, Thickened heart muscle (hypertrophic cardiomyopathy) |
Lungs and breathing | 2 | Pulmonary hypoplasia, Abnormal lung lobation |
Kidneys and urinary system | 2 | Cystic renal dysplasia, Enlarged kidney |
Bones and joints | 1 | Femoral bowing |